Sofinnova Investments, Inc.

Holdings History for SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN)

Symbol: SUPN on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	1.2%	+0.38%	$27,488,822	553,095	+176,029	+47%	$49.70	Q4 2025
30 Sep 2025	1.1%	-1.2%	$18,019,984	377,066	-422,187	-53%	$47.79	Q3 2025
30 Jun 2025	1.7%	+0.6%	$25,192,455	799,253	+278,575	+54%	$31.52	Q2 2025
31 Mar 2025	1.3%	+1.3%	$17,052,205	520,678	+520,678	NEW	$32.75	Q1 2025
31 Dec 2020		-0.54%	$0	0	-330,295	-100%	$51.30	Q4 2020
30 Sep 2020	0.54%	-0.24%	$6,883,000	330,295	-148,034	-31%	$20.84	Q3 2020
30 Jun 2020	0.78%	+0.78%	$11,359,000	478,329	+478,329	NEW	$23.75	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.